InsidersTradesSigma
Guard Therapeutics International AB (publ): management transactions · Finland · FIN-FSA
FI:guard-therapeutics-international-ab-publSE0024220180FI·FIN-FSAMcap 27M€Healthcare
Browse the full directors' dealings record of Guard Therapeutics International AB (publ), a listed issuer based in Finland. Shares are quoted on FI FI, under the authority of FIN-FSA. Operating in the Healthcare sector, Guard Therapeutics International AB (publ) has recorded 7 public disclosures. Market capitalisation: €26.8m. The latest transaction was disclosed on 9 April 2025 (Purchase). Among the most active insiders: Sara Jenny Thuresson. Every trade is openly available.
7
Insider Decl.
0
Thresholds
€30,357
5 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
1.33 €
Analyst consensus
1 analysts1.75 €Target 1.75 €(+32%)1.75 €
Income statement
Net income−108.9 M€0.0% margin
Valuation
PER (forward)0.5x
P/Book0.7x
Balance sheet & cash
Market cap26.8 M€
Free Cash Flow−109.3 M€
Profitability & ownership
ROE-172.7%
ROA-87.1%
% insiders28.7%
% institutions37.0%
Last declaration on 9 April 2025
Declarations7 total
Executives●Purchase20FIN-FSA
€8,2655,864 shares@ €1.40940.031% mcap100.0% of flow
BTA (betald tecknad aktie)
FI:A003N280-2·
Ideal exit: 30 Dec 2025 (T+270)
Executives●Purchase35FIN-FSA
€11,0957,872 shares@ €1.40940.041% mcap100.0% of flow
BTA (betald tecknad aktie)
FI:A003N203-1·
Ideal exit: 30 Dec 2025 (T+270)
Executives●Purchase17FIN-FSA
€2,1991,560 shares@ €1.40940.0082% mcap100.0% of flow
BTA (betald tecknad aktie)
FI:A003N205-1·
Ideal exit: 29 Dec 2025 (T+270)
Executives●Other8FIN-FSA
01,950 shares0
Teckningsrätt/Uniträtt
FI:A003N204-1·
Executives●Purchase30FIN-FSA
€3,2082,276 shares@ €1.40940.012% mcap100.0% of flow
BTA (betald tecknad aktie)
FI:A003N186-1·
Ideal exit: 29 Dec 2025 (T+270)
Executives●Other8FIN-FSA
0200 shares0
Teckningsrätt/Uniträtt
FI:A003N185-1·
Executives●Purchase19FIN-FSA
€5,5903,963 shares@ €1.41060.021% mcap100.0% of flow
BTA (betald tecknad aktie)
FI:A003N119-1·
Ideal exit: 27 Dec 2025 (T+270)
7 of 7 declarations